Literature DB >> 25843706

mTORC2 regulates cardiac response to stress by inhibiting MST1.

Sebastiano Sciarretta1, Peiyong Zhai2, Yasuhiro Maejima2, Dominic P Del Re2, Narayani Nagarajan2, Derek Yee2, Tong Liu3, Mark A Magnuson4, Massimo Volpe5, Giacomo Frati6, Hong Li3, Junichi Sadoshima7.   

Abstract

The mTOR and Hippo pathways have recently emerged as the major signaling transduction cascades regulating organ size and cellular homeostasis. However, direct crosstalk between two pathways is yet to be determined. Here, we demonstrate that mTORC2 is a direct negative regulator of the MST1 kinase, a key component of the Hippo pathway. mTORC2 phosphorylates MST1 at serine 438 in the SARAH domain, thereby reducing its homodimerization and activity. We found that Rictor/mTORC2 preserves cardiac structure and function by restraining the activity of MST1 kinase. Cardiac-specific mTORC2 disruption through Rictor deletion leads to a marked activation of MST1 that, in turn, promotes cardiac dysfunction and dilation, impairing cardiac growth and adaptation in response to pressure overload. In conclusion, our study demonstrates the existence of a direct crosstalk between mTORC2 and MST1 that is critical for cardiac cell survival and growth.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25843706      PMCID: PMC4417361          DOI: 10.1016/j.celrep.2015.03.010

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  51 in total

1.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

2.  Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1.

Authors:  Eric O'Neill; Linda Rushworth; Manuela Baccarini; Walter Kolch
Journal:  Science       Date:  2004-12-24       Impact factor: 47.728

Review 3.  TOR signaling in growth and metabolism.

Authors:  Stephan Wullschleger; Robbie Loewith; Michael N Hall
Journal:  Cell       Date:  2006-02-10       Impact factor: 41.582

4.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

5.  Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.

Authors:  Chiyo Shiota; Jeong-Taek Woo; Jill Lindner; Kathy D Shelton; Mark A Magnuson
Journal:  Dev Cell       Date:  2006-09-07       Impact factor: 12.270

6.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

7.  Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton.

Authors:  D D Sarbassov; Siraj M Ali; Do-Hyung Kim; David A Guertin; Robert R Latek; Hediye Erdjument-Bromage; Paul Tempst; David M Sabatini
Journal:  Curr Biol       Date:  2004-07-27       Impact factor: 10.834

8.  Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive.

Authors:  Estela Jacinto; Robbie Loewith; Anja Schmidt; Shuo Lin; Markus A Rüegg; Alan Hall; Michael N Hall
Journal:  Nat Cell Biol       Date:  2004-10-03       Impact factor: 28.824

9.  mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1).

Authors:  Juan M García-Martínez; Dario R Alessi
Journal:  Biochem J       Date:  2008-12-15       Impact factor: 3.857

10.  PKC-alpha regulates cardiac contractility and propensity toward heart failure.

Authors:  Julian C Braz; Kimberly Gregory; Anand Pathak; Wen Zhao; Bogachan Sahin; Raisa Klevitsky; Thomas F Kimball; John N Lorenz; Angus C Nairn; Stephen B Liggett; Ilona Bodi; Su Wang; Arnold Schwartz; Edward G Lakatta; Anna A DePaoli-Roach; Jeffrey Robbins; Timothy E Hewett; James A Bibb; Margaret V Westfall; Evangelia G Kranias; Jeffery D Molkentin
Journal:  Nat Med       Date:  2004-02-15       Impact factor: 53.440

View more
  52 in total

Review 1.  Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up.

Authors:  Alberto Roselló-Díez; Alexandra L Joyner
Journal:  Endocr Rev       Date:  2015-10-20       Impact factor: 19.871

Review 2.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

3.  Exploration of MST1-Mediated Secondary Brain Injury Induced by Intracerebral Hemorrhage in Rats via Hippo Signaling Pathway.

Authors:  Peng Zhang; Tianyi Wang; Dongping Zhang; Zhuwei Zhang; Shuai Yuan; Juyi Zhang; Jie Cao; Haiying Li; Xiang Li; Haitao Shen; Gang Chen
Journal:  Transl Stroke Res       Date:  2019-04-02       Impact factor: 6.829

Review 4.  New Insights Into the Role of mTOR Signaling in the Cardiovascular System.

Authors:  Sebastiano Sciarretta; Maurizio Forte; Giacomo Frati; Junichi Sadoshima
Journal:  Circ Res       Date:  2018-02-02       Impact factor: 17.367

Review 5.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

6.  H-ras Inhibits the Hippo Pathway by Promoting Mst1/Mst2 Heterodimerization.

Authors:  Sonali J Rawat; Daniela Araiza-Olivera; Luis E Arias-Romero; Olga Villamar-Cruz; Tatiana Y Prudnikova; Heinrich Roder; Jonathan Chernoff
Journal:  Curr Biol       Date:  2016-05-26       Impact factor: 10.834

Review 7.  Oncometabolic Tracks in the Heart.

Authors:  Heinrich Taegtmeyer; Anja Karlstaedt; Meredith L Rees; Giovanni Davogustto
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

8.  Yap/Taz mediates mTORC2-stimulated fibroblast activation and kidney fibrosis.

Authors:  Yuan Gui; Jianzhong Li; Qingmiao Lu; Ye Feng; Mingjie Wang; Weichun He; Junwei Yang; Chunsun Dai
Journal:  J Biol Chem       Date:  2018-08-28       Impact factor: 5.157

9.  Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction.

Authors:  Sebastiano Sciarretta; Derek Yee; Narayani Nagarajan; Franca Bianchi; Toshiro Saito; Valentina Valenti; Mingming Tong; Dominic P Del Re; Carmine Vecchione; Leonardo Schirone; Maurizio Forte; Speranza Rubattu; Akihiro Shirakabe; V Subbarao Boppana; Massimo Volpe; Giacomo Frati; Peiyong Zhai; Junichi Sadoshima
Journal:  J Am Coll Cardiol       Date:  2018-05-08       Impact factor: 24.094

Review 10.  Hras helps hippo heterodimerize to evade tumor suppression.

Authors:  Daniela Araiza-Olivera; Jonathan Chernoff
Journal:  Small GTPases       Date:  2016-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.